Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Launches Certified Service Program for MassArray

NEW YORK (GenomeWeb News) – Sequenom today said that it has launched a certified service program for its MassArray System and has named the first laboratory participants.

The San Diego-based firm said that certifications have been awarded to McGill University and Genome Quebec Innovation Centre in Montreal; Knight Diagnostic Laboratories at Oregon Health & Science University; GeneWorks in Adelaide, Australia; The Clinical Genomics Centre in Toronto; Karolinska University Hospital in Sweden; NewGene in Newcastle, UK; DNA LandMarks, which is a plant and animal genomics subsidiary of BASF and is based in Quebec; and several unnamed labs based in Asia.

Participants in the CSP are certified for offering research services on the MassArray System, a MALDI-TOF-based mass spectrometry system for a variety of genomic analysis applications.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.